Heterobivalent Ligand for the Adenosine A2A-Dopamine D2 Receptor Heteromer

被引:13
|
作者
Pulido, Daniel [1 ,2 ]
Casado-Anguera, Veronica [3 ]
Gomez-Autet, Marc [4 ]
Llopart, Natalia [3 ]
Moreno, Estefania [3 ]
Casajuana-Martin, Nil [4 ]
Ferre, Sergi [5 ]
Pardo, Leonardo [4 ]
Casado, Vicent [3 ]
Royo, Miriam [1 ,2 ]
机构
[1] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Barcelona 08034, Spain
[2] Inst Adv Chem Catalonia IQAC, Dept Surfactants & Nanobiotechnol, CSIC, Barcelona 08034, Spain
[3] Univ Barcelona, Inst Biomed Univ Barcelona IBUB, Fac Biol, Dept Biochem & Mol Biomed, Barcelona 08028, Spain
[4] Univ Autonoma Barcelona, Fac Med, Unitat Bioestadist, Lab Med Computac, Bellaterra 08193, Spain
[5] NIDA, Integrat Neurobiol Sect, Intramural Res Program, NIH, Baltimore, MD 21224 USA
关键词
PROTEIN-COUPLED RECEPTORS; BIVALENT LIGANDS; RECOGNITION PATHWAY; BITOPIC LIGANDS; A(2A) RECEPTOR; GPCR DIMERS; BINDING; DESIGN; FLUORESCENCE; DIMERIZATION;
D O I
10.1021/acs.jmedchem.1c01763
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A G protein-coupled receptor heteromer that fulfills the established criteria for its existence in vivo is the complex between adenosine A(2A) (A(2A)R) and dopamine D-2 (D2R) receptors. Here, we have designed and synthesized heterobivalent ligands for the A(2A)R-D-2R heteromer with various spacer lengths. The indispensable simultaneous binding of these ligands to the two different orthosteric sites of the heteromer has been evaluated by radioligand competition-binding assays in the absence and presence of specific peptides that disrupt the formation of the heteromer, label-free dynamic mass redistribution assays in living cells, and molecular dynamic simulations. This combination of techniques has permitted us to identify compound 26 [K-DB1 (A(2A)R) = 2.1 nM, K-DB1 (D2R) = 0.13 nM], with a spacer length of 43-atoms, as a true bivalent ligand that simultaneously binds to the two different orthosteric sites. Moreover, bioluminescence resonance energy transfer experiments indicate that 26 favors the stabilization of the A(2A)R-D2R heteromer.
引用
收藏
页码:616 / 632
页数:17
相关论文
共 50 条
  • [1] Adenosine A2A-dopamine D2 receptor heteromers in schizophrenia
    Ciruela, F.
    Lopez-Cano, M.
    Callado, L.
    Aso, E.
    Contreras, F.
    Altafaj, X.
    Masahiko, M.
    Fernandez-Duenas, V.
    Menchon, Jose. M.
    Valle-Leon, M.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2019, 150 : 179 - 179
  • [2] Unique effect of clozapine on adenosine A2A-dopamine D2 receptor heteromerization
    Valle-Leon, Marta
    Casajuana-Martin, Nil
    del Torrent, Claudia Llinas
    Argerich, Josep
    Gomez-Acero, Laura
    Sahlholm, Kristoffer
    Ferre, Sergi
    Pardo, Leonardo
    Ciruela, Francisco
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2023, 160
  • [3] Evidence for the heterotetrameric structure of the adenosine A2A-dopamine D2 receptor complex
    Casado-Anguera, Veronica
    Bonaventura, Jordi
    Moreno, Estefania
    Navarro, Gemma
    Cortes, Antoni
    Ferre, Sergi
    Casado, Vicent
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2016, 44 : 595 - 600
  • [4] Decreased striatal adenosine A2A-dopamine D2 receptor heteromerization in schizophrenia
    Marta Valle-León
    Luis F. Callado
    Ester Aso
    María M. Cajiao-Manrique
    Kristoffer Sahlholm
    Marc López-Cano
    Concepció Soler
    Xavier Altafaj
    Masahiko Watanabe
    Sergi Ferré
    Víctor Fernández-Dueñas
    José M. Menchón
    Francisco Ciruela
    [J]. Neuropsychopharmacology, 2021, 46 : 665 - 672
  • [5] Behavioral control by striatal adenosine A2A-dopamine D2 receptor heteromers
    Taura, J.
    Valle-Leon, M.
    Sahlholm, K.
    Watanabe, M.
    Van Craenenbroeck, K.
    Fernandez-Duenas, V.
    Ferre, S.
    Ciruela, F.
    [J]. GENES BRAIN AND BEHAVIOR, 2018, 17 (04)
  • [6] ILLUMINATING THE ADENOSINE A2A-DOPAMINE D2 RECEPTOR OLIGOMER IN PARKINSON'S DISEASE
    Fernandez-Duenas, V
    Taura, J.
    Jacobson, K. A.
    Ferre, S.
    Ciruela, F.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 18 - 18
  • [7] Adenosine A2A-dopamine D2 receptor-receptor interaction in neurons and astrocytes: Evidence and perspectives
    Guidolin, Diego
    Marcoli, Manuela
    Tortorella, Cinzia
    Maura, Guido
    Agnati, Luigi F.
    [J]. OLIGOMERIZATION IN HEALTH AND DISEASE: FROM ENZYMES TO G PROTEIN-COUPLED RECEPTORS, 2020, 169 : 247 - 277
  • [8] A new D2 dopamine receptor agonist allosterically modulates A2A adenosine receptor signalling by interacting with the A2A/D2 receptor heteromer
    Trincavelli, Maria Letizia
    Daniele, Simona
    Orlandini, Elisabetta
    Navarro, Gemma
    Casado, Vicent
    Giacomelli, Chiara
    Nencetti, Susanna
    Nuti, Elisa
    Macchia, Marco
    Huebner, Harald
    Gmeiner, Peter
    Rossello, Armando
    Lluis, Carmen
    Martini, Claudia
    [J]. CELLULAR SIGNALLING, 2012, 24 (04) : 951 - 960
  • [9] Mapping the Interface of a GPCR Dimer: A Structural Model of the A2A Adenosine and D2 Dopamine Receptor Heteromer
    Borroto-Escuela, Dasiel O.
    Rodriguez, David
    Romero-Fernandez, Wilber
    Kapla, Jon
    Jaiteh, Mariama
    Ranganathan, Anirudh
    Lazarova, Tzvetana
    Fuxe, Kjell
    Carlsson, Jens
    [J]. FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [10] Adenosine A2A-dopamine D2 receptor-receptor heteromers.: Targets for neuro-psychiatric disorders
    Ferré, S
    Ciruela, F
    Canals, M
    Marcellino, D
    Burgueno, J
    Casadó, V
    Hillion, J
    Torvinen, M
    Fanelli, F
    de Benedetti, P
    Goldberg, SR
    Bouvier, M
    Fuxe, K
    Agnati, LF
    Lluis, C
    Franco, R
    Woods, A
    [J]. PARKINSONISM & RELATED DISORDERS, 2004, 10 (05) : 265 - 271